ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2025

Lower Mortality Risk Associated With Remdesivir + Dexamethasone Versus Dexamethasone Alone for the Treatment of Patients Hospitalized for COVID-19.

Essy Mozaffari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.